类风湿关节炎患者使用抗SARS-CoV-2 mRNA疫苗。 - Suppr

Suppr

超能文献

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis.

作者信息

Rubbert-Roth Andrea, Vuilleumier Nicolas, Ludewig Burkhard, Schmiedeberg Kristin, Haller Christoph, von Kempis Johannes

机构信息

Division of Rheumatology, Kantonsspital St Gallen, St Gallen, Switzerland.

Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.

出版信息

Lancet Rheumatol. 2021 Jul;3(7):e470-e472. doi: 10.1016/S2665-9913(21)00186-7. Epub 2021 Jun 8.

DOI:10.1016/S2665-9913(21)00186-7

PMID:34124693

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8186851/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e55/8186851/9492d14edc29/gr1_lrg.jpg

相似文献

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis.类风湿关节炎患者使用抗SARS-CoV-2 mRNA疫苗。

Lancet Rheumatol. 2021 Jul;3(7):e470-e472. doi: 10.1016/S2665-9913(21)00186-7. Epub 2021 Jun 8.

[CME Rheumatology 23: Rheumatoid Arthritis Following COVID-19/SARS-CoV-2 Infection].[继续医学教育风湿病学23：新冠病毒感染后类风湿关节炎]

Praxis (Bern 1994). 2021 Apr;110(6):293-297. doi: 10.1024/1661-8157/a003670.

[CME Rheumatology 23/Answers: Rheumatoid Arthritis Following COVID-19/SARS-CoV-2 Infection].[继续医学教育风湿病学23/答案：新型冠状病毒肺炎/严重急性呼吸综合征冠状病毒2感染后的类风湿关节炎]

Praxis (Bern 1994). 2021;110(7):375-376. doi: 10.1024/1661-8157/a003671.

Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection.脂质纳米颗粒 RBD-hFc mRNA 疫苗可保护 hACE2 转基因小鼠免受致死性 SARS-CoV-2 感染。

Nano Lett. 2021 Jun 9;21(11):4774-4779. doi: 10.1021/acs.nanolett.1c01284. Epub 2021 May 25.

Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle?mRNA 新型冠状病毒疫苗是否会影响患者在试管婴儿-胚胎移植周期中的表现？

Reprod Biol Endocrinol. 2021 May 13;19(1):69. doi: 10.1186/s12958-021-00757-6.

Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT - IRCCS "Fondazione Pascale" Cancer Center (Naples, Italy).意大利那不勒斯“帕斯卡尔基金会”癌症中心（INT - IRCCS）医护人员的疫苗接种策略及抗SARS-CoV-2 S抗体滴度

Infect Agent Cancer. 2021 May 12;16(1):32. doi: 10.1186/s13027-021-00375-2.

False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.慢性炎症性疾病患者样本的 SARS-CoV-2 血清学检测中出现假阳性结果。

Front Immunol. 2021 May 3;12:666114. doi: 10.3389/fimmu.2021.666114. eCollection 2021.

Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.接受血液透析患者接种 1 剂 BNT162b2 疫苗后的短期抗体反应。

CMAJ. 2021 May 31;193(22):E793-E800. doi: 10.1503/cmaj.210673. Epub 2021 May 12.

Infection and mRNA-1273 vaccine antibodies neutralize SARS-CoV-2 UK variant.感染和mRNA-1273疫苗抗体可中和新冠病毒英国变种。

medRxiv. 2021 Feb 5:2021.02.02.21250799. doi: 10.1101/2021.02.02.21250799.

A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2.一种针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的可扩展局部载体候选疫苗。

Vaccines (Basel). 2020 Aug 24;8(3):472. doi: 10.3390/vaccines8030472.

引用本文的文献

Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies.SARS-CoV-2疫苗接种后自身免疫性疾病患者免疫原性受关注程度增加：当前研究的荟萃分析与系统评价

Ann Med. 2025 Dec;57(1):2478319. doi: 10.1080/07853890.2025.2478319. Epub 2025 Mar 26.

Safety of CoronaVac and ChAdOx1 vaccines against SARS-CoV-2 in patients with rheumatoid arthritis: data from the Brazilian multicentric study safer.CoronaVac 和 ChAdOx1 疫苗在类风湿关节炎患者中预防 SARS-CoV-2 的安全性：来自巴西多中心研究 safer 的数据。

Adv Rheumatol. 2024 Aug 12;64(1):58. doi: 10.1186/s42358-024-00397-5.

4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients.风湿免疫病患者接种第 4 剂 SARS-CoV-2 异源和同源加强疫苗。

Front Immunol. 2024 Jul 26;15:1427501. doi: 10.3389/fimmu.2024.1427501. eCollection 2024.

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.4 项随机对照试验中免疫系统较弱的参与者的 COVID-19 疫苗效力。

Clin Infect Dis. 2024 Aug 16;79(2):364-374. doi: 10.1093/cid/ciae192.

COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases.免疫介导的炎症性疾病中的 COVID-19 疫苗接种与免疫抑制治疗

Vaccines (Basel). 2023 Dec 4;11(12):1813. doi: 10.3390/vaccines11121813.

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals.BNT162b2 疫苗在免疫功能低下个体中针对 SARS-CoV-2 德尔塔变异株的有效性和保护作用的衰减。

Front Immunol. 2023 Nov 2;14:1247129. doi: 10.3389/fimmu.2023.1247129. eCollection 2023.

Intracranial Hemorrhage After Pfizer-BioNTech (BNT162b2) mRNA COVID-19 Vaccination: A Case Report.辉瑞-生物科技（BNT162b2）mRNA新冠疫苗接种后颅内出血：一例报告

Cureus. 2023 Apr 18;15(4):e37747. doi: 10.7759/cureus.37747. eCollection 2023 Apr.

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.疫苗类型和免疫抑制治疗，但不是诊断，对风湿性疾病患者 COVID-19 疫苗接种后的抗体反应有重要影响。

RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002650.

The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review.皮肤病免疫调节治疗对COVID-19疫苗免疫反应的影响：一项叙述性综述。

Curr Dermatol Rep. 2022;11(4):263-288. doi: 10.1007/s13671-022-00376-3. Epub 2022 Oct 25.

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA.接种疫苗后抗 SARS-CoV-2 中和抗体滴度可预测 RA 患者 24 周内的抗 S IgG 水平。

RMD Open. 2022 Oct;8(2). doi: 10.1136/rmdopen-2022-002575.

本文引用的文献

In Search of the SARS-CoV-2 Protection Correlate: Head-to-Head Comparison of Two Quantitative S1 Assays in Pre-characterized Oligo-/Asymptomatic Patients.寻找新冠病毒（SARS-CoV-2）的保护相关指标：对预先确定的寡症状/无症状患者的两种定量S1检测方法进行直接比较

Infect Dis Ther. 2021 Jun 16:1-14. doi: 10.1007/s40121-021-00475-x.

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.单剂 Ad26.COV2.S 疫苗预防新冠病毒的安全性和有效性。

N Engl J Med. 2021 Jun 10;384(23):2187-2201. doi: 10.1056/NEJMoa2101544. Epub 2021 Apr 21.

Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay.针对 SARS-CoV-2 刺突蛋白受体结合域的总抗体的快速高通量自动化电化学发光免疫分析与中和测定的比较性能。

J Clin Virol. 2021 Jun;139:104820. doi: 10.1016/j.jcv.2021.104820. Epub 2021 Apr 10.

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort.在一项单中心队列研究中，慢性炎症性疾病和免疫抑制治疗患者的抗 SARS-CoV-2 mRNA 疫苗的免疫原性和安全性。

Ann Rheum Dis. 2021 Oct;80(10):1306-1311. doi: 10.1136/annrheumdis-2021-220272. Epub 2021 Mar 24.

Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.风湿性和肌肉骨骼疾病患者对单剂SARS-CoV-2 mRNA疫苗的抗体反应。

Ann Rheum Dis. 2021 Aug;80(8):1098-1099. doi: 10.1136/annrheumdis-2021-220289. Epub 2021 Mar 23.

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。

N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.两种基于 RNA 的新冠候选疫苗的安全性和免疫原性。

N Engl J Med. 2020 Dec 17;383(25):2439-2450. doi: 10.1056/NEJMoa2027906. Epub 2020 Oct 14.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验